Intravenous Therapy Articles & Analysis
1 articles found
As such, patients who complete or discontinue bone-forming therapy are often advised to transition to another osteoporosis therapy to prevent bone loss.(5) Antiresorptive therapies are a common choice, and transitioning to alendronate (ALN) or other bisphosphonates can preserve and, in some cases, further enhance BMD gains.(6-10) Although no ...